The board may exempt a particular drug product from the requirements of KRS 217.907, upon application of a manufacturer or distributor showing that the drug product's size, texture, or other unique characteristics render imprinting impractical or impossible.
KRS 217.911
Created 1982 Ky. Acts ch. 5, sec. 4, effective7/15/1982.